China’s Fosun group has agreed to pare its proposed holding in the Indian injectables firm Gland Pharma Ltd. as part of certain revised terms pertaining to the mega deal, currently in limbo in India.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?